| 注册
首页|期刊导航|临床医学工程|舒血宁对经皮冠脉介入患者血管内皮功能及主要不良心血管事件的影响

舒血宁对经皮冠脉介入患者血管内皮功能及主要不良心血管事件的影响

李纪松 梁伟 寇广亚

临床医学工程2024,Vol.31Issue(5):603-604,2.
临床医学工程2024,Vol.31Issue(5):603-604,2.DOI:10.3969/j.issn.1674-4659.2024.05.0603

舒血宁对经皮冠脉介入患者血管内皮功能及主要不良心血管事件的影响

Influence of Shuxuening on Vascular Endothelial Function and Major Adverse Cardiovascular Events in Patients with Percutaneous Coronary Intervention

李纪松 1梁伟 1寇广亚1

作者信息

  • 1. 新乡市第二人民医院心内科,河南新乡 453000
  • 折叠

摘要

Abstract

Objective To explore the effects of Shuxuening on endothelial function and major adverse cardiovascular events(MACE)in patients with percutaneous coronary intervention(PCI).Methods 60 PCI patients in our hospital were divided into observation group and control group.The control group was treated with atorvastatin,while the observation group was treated with Shuxuening on the basis of the control group.The levels of inflammatory factors,vascular endothelial function and incidence of MACE were compared between two groups.Results After treatment,the C-reactive protein(CRP),interleukin-6(IL-6),endothelin(ET)and von Willebrand factor(vWF)levels of the two groups decreased,and the CRP,IL-6,ET and vWF levels of the observation group were lower than those of the control group(P<0.05).The incidence of MACE in the observation group was 6.67%,significantly lower than 30.00%in the control group(P<0.05).Conclusions Shuxuening can reduce the levels of inflammatory factors and the incidence of MACE in patients after PCI,and improve the vascular endothelial function,which is worthy of clinical promotion and application.

关键词

舒血宁/经皮冠脉介入/炎症因子/血管内皮功能/主要不良心血管事件

Key words

Shuxuening/Percutaneous coronary intervention/Inflammatory factor/Vascular endothelial function/Major adverse cardiovascular event

分类

医药卫生

引用本文复制引用

李纪松,梁伟,寇广亚..舒血宁对经皮冠脉介入患者血管内皮功能及主要不良心血管事件的影响[J].临床医学工程,2024,31(5):603-604,2.

临床医学工程

1674-4659

访问量0
|
下载量0
段落导航相关论文